Universidad Autónoma de Madrid

Special issue “Diabetic nephropathy: Diagnosis, prevention and treatment”

Biblos-e Archivo/Manakin Repository

UAM_Biblioteca

Special issue “Diabetic nephropathy: Diagnosis, prevention and treatment”

Metadatos
Title: Special issue “Diabetic nephropathy: Diagnosis, prevention and treatment”
Author: Ruiz-Ortega, Marta; Rodrigues-Diez, Raul R.; Lavoz, Carolina; Rayego-Mateos, Sandra
Entity: UAM. Departamento de Medicina; Instituto de Investigación Sanitaria Fundación Jiménez Díaz (ISS-FJD)
UAM Author: Ruiz Ortega, Marta ; Rodrigues Díez, Raúl
Publisher: MDPI, Basel, SMwitzerland
Date: 2020-03-15
Citation: Journal of Clinical Medicine 9.3 (2020): 813
ISSN: 2077-0383
DOI: 10.3390/jcm9030813
Funded by: Editors are funding by Grants from the Instituto de Salud Carlos III(ISCIII) and Fondos FEDER European Union (PI17/00119 and Red de Investigación Renal (REDINREN): RD16/0009, to M.R-O), Comunidad de Madrid (“NOVELREN” B2017/BMD-3751 to M.R-O); the José Castillejo grant (CAS19/00133 to R.R.R-D); the “Juan de la Cierva Formacion” training program of the Ministerio de Economia, Industria y Competitividad (MINECO) supported the salary of SR-M (FJCI-2016-29050); Sociedad Española de Nefrologia (S.E.N. to M.R-O). Grants PAI 82140017 to C.L. of Chile; IMPROVE-PD project (“Identification and Management of Patients atRisk–Outcome and Vascular Events in Peritoneal Dialysis”) funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie Grant Agreement No. 812699 to M.R.O.
Project: Gobierno de España. PI17/00119; Gobierno de España. RD16/0009, to M.R-O; Comunidad de Madrid. B2017/BMD-3751/NOVELREN; info:eu-repo/grantAgreement/EC/H2020/812699/EU//MS-C
Editor's Version: http://doi.org/10.3390/jcm9030813
Subjects: Chronic kidney disease; Diabetic nephropathy; Biomarkers; Treatment; Medicina
URI: http://hdl.handle.net/10486/693619
Rights: © 2020 The Authors

Licencia Creative Commons
Esta obra está bajo una Licencia Creative Commons Atribución 4.0 Internacional.

Abstract:

Diabetic nephropathy (DN) is the main cause of end-stage renal disease. DN is a complex disease mediated by genetic and environmental factors, and many cellular and molecular mechanisms are involved in renal damage in diabetes. There are no biomarkers that reflect the severity of the underlying renal histopathological changes and can e ectively predict the progression of renal damage and stratify the risk of DN among individuals with diabetes mellitus. Current therapeutic strategies are based on the strict control of glucose and blood pressure levels and, although there are new anti-diabetic drugs, these treatments only retard renal damage progression, being necessary novel therapies. In this Special Issue, there are several comprehensive reviews and interesting original papers covering all these topics, which would be of interest to the growing number of readers of the Journal of Clinical Medicine

Show full item record

Files in this item

Icon
Name: special_ruiz_JCM_ ...
Size: 186.2Kb
Format: PDF
Share

Delicious Save this on Delicious

Citations
G o o g l e ™ Scholar: Ruiz-Ortega, Marta - Rodrigues-Diez, Raul R. - Lavoz, Carolina - Rayego-Mateos, Sandra

This item appears in the following Collection(s)